TI
INFI

Trexquant Investment’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Trexquant Investment’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-89,344
Closed -$471K – 1167
2016
Q1 		$471K Buy
+89,344
New +$547K 0.06% 568
2015
Q3 		– Sell
-129,300
Closed -$1.42M – 1320
2015
Q2 		$1.42M Buy
129,300
+48,800
+61% +$626K 0.16% 207
2015
Q1 		$1.13M Buy
+80,500
New +$1.23M 0.11% 307

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's INFI Position: Q2 2016 in Review

Trexquant Investment sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 89,344 shares — an estimated $471K sold.

Trexquant Investment first reported a position in INFI in Q1 2015 and held it in 3 quarters. The position peaked at $1.42M in Q2 2015. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

  • Trexquant Investment reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Trexquant Investment sold 89,344 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $471K.
  • Trexquant Investment first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Trexquant Investment's Infinity Pharmaceuticals, Inc. position peaked at $1.42M in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Trexquant Investment's 13F filing for Q2 2016, filed 10 Aug 2016.